FDA Updates Testosterone Labeling for Blood Pressure and Cardiovascular Risks. Anderer S. JAMA 2025 Apr 4. doi: 10.1001/jama.2025.3240.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderer S. FDA Updates Testosterone Labeling for Blood Pressure and Cardiovascular Risks. JAMA 2025 Apr 4. doi: 10.1001/jama.2025.3240.
PMID: 40184062